Chronic Lymphocytic Leukemia

Jan A. Burger, MD, PhD and Javier Pinilla-Ibarz, MD, PhD shed light on the field of CLL and the transformative role of ibrutinib.

An overview of emerging targeted therapies and immunotherapies in chronic lymphocytic leukemia.

An overview of the factors affecting prognosis and treatment in chronic lymphocytic leukemia.

Current treatment strategies for chronic lymphocytic leukemia (CLL).

<p>CLL is a malignancy characterized by the clonal proliferation and accumulation of small, mature-appearing CD5-positive B lymphocytes in the blood, bone marrow, and secondary lymphoid tissues.</p>